Top of this page
Skip navigation, go straight to the content

Clinical Study Information - CDP323

Disease area
studied
Abbreviated title Phase Study ID Registry database Study results Study summary Publication (if available)
Multiple Sclerosis Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323 Phase 2 C32322
Terminated
NCT00484536
2006-002204-33

LINK
Polman, C. et al. Neurology;3-2-2010;74;9 Suppl. 2;A293 62nd Annual Meeting of the American Academy of Neurology (AAN), April 10-17, 2010;Toronto, Canada
Multiple Sclerosis CDP323 Biomarker Study Phase 2 C32325
Completed
NCT00726648

Wolf et al. PLoS ONE;2013;8;3;e58438.